• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in utero do not develop neurological disorders such as hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to weigh the benefits of taking it versus the dangers for the foetus. Doctors don't have enough data to make unambiguous recommendations but they can provide information on risks and benefits to assist pregnant women to make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy did not have a greater risk of fetal malformations, or structural birth defects. Researchers used a vast population-based study of case-control to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during early pregnancy, and those who did not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to minimize any bias.

The study of the researchers had some limitations. The researchers were not able, in the first place to distinguish the effects of the medication from the disorder. This limitation makes it difficult for researchers to establish whether the few associations observed between the groups exposed were due to medication use or if they were affected by co-morbidities. In addition the study did not study long-term offspring outcomes.

The study did show that infants whose mothers took ADHD medications during pregnancy were at a slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than those who were born without any medication or had cut back on their medications prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits for both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, if they are able, assist them in developing strategies for improving their coping skills that can lessen the negative impact of her condition on her daily life and relationships.

Medication Interactions

Many doctors are faced with the decision of whether to maintain treatment or stop during pregnancy as more women are diagnosed with ADHD. Most of the time, these decisions are taken in the absence of solid and reliable evidence in either case, which means that doctors must weigh their knowledge from their own experiences, those of other doctors, and what research suggests on the subject and their own best medication for adhd combined type judgment for each individual patient.

The issue of possible risks for infants can be particularly tricky. The research on this issue is based on observations rather than controlled studies, and a lot of the results are conflicting. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these limitations by examining data on both live and deceased births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies have shown a neutral, or even slightly negative, impact. Therefore, a careful risk/benefit assessment must be conducted in every instance.

For many women with ADHD, the decision to stop medication can be difficult, if not impossible. In an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for these patients. A loss of medication may also impact the ability to safely drive and perform work-related tasks, which are essential aspects of normal life for people with ADHD.

She suggests that women who are not sure whether to continue taking the medication or stop it due to their pregnancy should educate family members, colleagues, and their friends about the condition, the effects on daily functioning, and the benefits of keeping the current treatment regimen. It can also aid in ensuring that the woman feels supported when she is struggling with her decision. It is important to note that some medications can pass through the placenta, so if the patient decides to discontinue her ADHD medication during pregnancy and breastfeeding, she must be aware that the effects of the drug can be transferred to the infant.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about the effects that the drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this subject. Using two massive data sets, researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medications increased the risk of birth defects. While the overall risk remains low estrogen and adhd medication, the scientists discovered that the first-trimester exposure to ADHD medicines was associated with an increased risk of specific heart defects, like ventriculo-septal defects (VSD).

The authors of the study didn't discover any link between early medication usage and other congenital anomalies, like facial deformities, or club feet. The results are in line with previous studies that showed a small, but significant increase in cardiac malformations for women who started taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter stages of pregnancy, when a lot of women decided to stop taking their medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to have caesarean section, low Apgar score following delivery, and a baby that required help breathing at birth. The researchers of the study were not able to eliminate bias due to selection because they restricted the study to women with no other medical conditions that might have contributed to the findings.

Researchers hope their research will provide doctors with information when they see pregnant women. They advise that while the discussion of risks and benefits is important but the decision to stop or maintain medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, even though stopping the medication is an option to think about, it isn't recommended due to the high prevalence of depression and mental health issues for women who are pregnant or recently gave birth. Furthermore, research suggests that women who decide to stop their medications are more likely to experience a difficult time adjusting to life without them after the birth of their baby.

Nursing

It can be a challenge to become a mother. Women who suffer from ADHD are often faced with a number of difficulties when they must manage their symptoms, attend doctor appointments and prepare for the birth of their child and adjust to a new routine. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications pass through breast milk in very small quantities, so the risk for breastfeeding infant is minimal. However, the rate of exposure to medications by the infant can differ based on dosage, how to get adhd medication without diagnosis (mouse click the next web page) often it is administered, and the time of day it is administered. Additionally, different drugs enter the infant's system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't completely comprehended.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. This is a complicated decision for the patient, who must weigh the benefits of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and whether they plan or are taking to take medication during the perinatal time.

Many studies have shown that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. In response, a rising number of patients are choosing to continue their medication. They have concluded through consultation with their physicians, that the benefits of continuing their current medication outweigh any risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non amphetamine adhd medication-pharmacological strategies. Psychoeducation is also necessary to help pregnant women with ADHD understand the symptoms and the underlying disorder. They should also be educated about treatment options and reinforce strategies for coping. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.